Inspire Medical Systems (INSP) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.14
- Estimate
- $0.09
- Surprise
- +54.1%
- Revenue (period 2026-09-30)
- $206.7M
- Score at report (before → after)
- 4.7 → 4.7/10
Revenue source: xbrl.
How the report landed
Inspire Medical Systems (INSP) beat the $0.09 estimate with adjusted EPS of $0.14 — a large 54.1% upside surprise. TrendMatrix's engine moved from Buy (Wait) (4.7/10) to Sell at 4.7/10 after the report.
Coverage in the report window
- Baird Maintains Neutral on Inspire Medical Systems, Raises Price Target to $77 — benzinga, 2026-11-03
- Inspire Medical Systems Narrows FY2026 Adj EPS Guidance from $1.05-$1.45 to $1.20-$1.40 vs $1.25 Est; Narrows FY2026 Sal — benzinga, 2026-11-02
Where TrendMatrix's rating stands now
TrendMatrix currently rates INSP Sell at 4.8/10.
4 of the last 4 quarters beat the estimate; this quarter's +54.1% surprise compares with a +122.9% four-quarter average.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (4/4)
What argues against it
- Concentration risk — Product: Inspire system
- Earnings expected to decline ~66% (cyclical peak)
- Analyst target reached - limited upside remaining
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $67.21
- Stop
- $63.83
Forward estimates sit below the trailing run-rate (43.6× forward vs 14.8× trailing) — consensus expects earnings to decline from here.
Model outputs from TrendMatrix’s engine as of 2026-11-03 — shown for context, not personalized investment advice.
INSP at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Devices
- Market cap
- $1.94B
- P/E (fwd)
- 43.6
- P/E (ttm)
- 14.8
- 52-week range
- $38.91–$147.03
- Off 52-week high
- 54.3%
- RSI (14)
- 45
- Volume vs avg
- 1.38×
- Score today
- 4.8/10